Shine taps new general manager for therapeutics division

By staff writers

May 23, 2022 -- Medical isotope firm Shine Medical Technologies has named Chris Vessell as general manager of the company's therapeutics division.

Vessell will oversee a team that is developing lutetium-177 for cancer therapies. He brings more than 25 years of experience in healthcare, manufacturing, and financial services, and he recently served as the U.S. nuclear medicine supply chain lead for GE Healthcare's Pharmaceutical Diagnostics group.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking